세계의 제조 실행 시스템 시장 : 업계 동향 및 예측 - 전개 유형별, 최종 사용자별, 주요 지역별
Manufacturing Execution System Market: Industry Trends and Global Forecasts - Distribution by Type of Deployment, Type of End-User and Key Geographical Regions
상품코드:1771308
리서치사:Roots Analysis
발행일:2025년 07월
페이지 정보:영문 119 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 제조 실행 시스템 시장 : 개요
세계의 제조 실행 시스템 시장 규모는 2035년까지 예측 기간 동안 16.02%의 연평균 복합 성장률(CAGR)로 확대될 전망이며, 현재 39억 9,000만 달러에서 2035년까지 204억 6,000만 달러로 성장할 것으로 예측됩니다.
시장 세분화는 시장 규모 및 시장 기회를 다음 매개 변수로 구분합니다.
전개 유형별
클라우드
기업 데이터센터
하이브리드
온프레미스
최종 사용자별
생명과학 및 바이오테크놀러지 기업
의료기기 제공업체
제약회사 및 기타
주요 지역별
북미
유럽
아시아태평양
라틴아메리카
중동?북아프리카
세계의 제조 실행 시스템 시장 : 성장 및 동향
수년 동안 헬스케어 산업은 상당한 성장을 이루고 있으며, 진화하는 시장 상황에서 관련성과 경쟁력을 유지하기 위해 제조업체는 새로운 기술과 도구의 도입이 필수적입니다. 제조 실행 시스템은 헬스케어 산업에서 장기적인 경쟁 우위를 확보하는데 중요한 역할을 합니다. 제조 실행 시스템은 복잡한 제조 공정의 다양한 프로세스를 연결, 모니터링 및 동기화하는 동적 정보 시스템입니다. MES 시스템은 공장 생산성 및 효율성을 향상시키고 전체 제조 공정의 유연성 및 민첩성을 향상시킵니다. 또한 규제 가이드라인을 준수하는 프로세스를 간소화하고 헬스케어 기업이 제조 공정에서 높은 품질 기준을 유지할 수 있도록 합니다.
최근 몇몇 헬스케어 이해관계자들은 생산 실행 시스템을 생산 라인에 통합하기 위한 노력을 적극적으로 실시했습니다. 게다가 이 영역에 종사하는 기업들은 사물인터넷(IoT)과 인공지능(AI) 등 선진 기술을 통합해 다양한 소스에서 대량의 데이터를 수집하고 분석해 인사이트, 예측, 행동의 형태로 가치를 창출하고 있습니다. 헬스케어 산업이 제조 실행 시스템으로 눈을 돌려 생산라인에 대한 데이터 주도 의사결정을 함으로써 산업 프로세스의 미래는 더 높은 효율성과 더 나은 성장 기회를 약속합니다.
세계의 제조 실행 시스템 시장 : 주요 인사이트
본 보고서에서는 세계의 제조 실행 시스템 시장의 현황을 파헤쳐 산업계에서의 잠재적인 성장 기회를 특정하고 있습니다. 주요 조사 결과는 다음과 같습니다.
현재, 헬스케어 분야의 생산 공정를 감시, 추적, 제어하기 위해 세계 75개 이상의 회사가 제조 실행 시스템(MES)을 제공하고 있다고 주장하고 있습니다.
이해관계자는 제약, 생명과학 및 바이오테크놀러지, 의료기기 업계를 위한 다양한 라이선스 모델을 통해 수많은 유형의 소프트웨어와 통합된 MES를 제공합니다.
MES 제공업체의 85% 이상이 구독 모델로 서비스를 제공하고 있어 의료기기 업계는 이러한 서비스의 유력한 최종 사용자로 부상하고 있습니다.
ERP와 PLM은 가장 두드러진 통합 소프트웨어로 부상하고 있으며, 50% 가까이의 이해관계자가 복수의 소프트웨어와 통합한 MES를 제공합니다.
15% 근처의 이해관계자가 모든 최종 사용자에게 MES를 제공하고 있다고 주장하고 있으며, 주요 예로는 Atachi Systems, Dassault Systemes, Epicor, GE Digital, Info, Tulip 등을 들 수 있습니다.
세계 고객의 진화하는 요구에 대응하기 위해 이해 관계자는 다양한 지역에 진출하고 있습니다.
이해관계자의 관심이 높아지고 있는 것은 파트너십 활동 증가로부터도 분명하고, 사실, 과거 2년간에서 가장 많은 제휴가 맺어지고 있습니다.
경쟁 우위를 구축하기 위해 제조 실행 시스템 공급자는 기존의 능력을 적극적으로 업그레이드하여 각각의 서비스 및 제품 제공을 더욱 강화하고 있습니다.
당사의 독자적인 가치 창조 프레임워크에서는 이 분야의 신흥 기업이 MES 포트폴리오를 강화하기 위해 통합해야 하는 주요 툴과 기술을 하이라이트하고 있습니다.
이 시장은 향후 10년간 16% 이상의 건전한 성장이 예상되고 있으며, 그 기회는 다양한 도입 형태, 최종 사용자, 다양한 지역에 분산되어 있다고 생각됩니다.
세계의 제조 실행 시스템 시장 : 주요 부문
시장은 도입 유형별로 클라우드, 엔터프라이즈 데이터센터, 하이브리드 및 온프레미스로 구분됩니다. 현재 클라우드 기반 MES 솔루션에 대한 수요가 증가함에 따라 클라우드 부문이 세계 제조 실행 시스템 시장에서 최대(-69%)의 점유율을 차지하고 있습니다. 그러나 하이브리드 부문은 예측 기간 동안 더 높은 CAGR로 성장할 것으로 예상됩니다.
최종 사용자 유형별로 시장은 생명 과학 및 바이오테크놀러지 기업, 의료기기 공급자, 제약 회사 등으로 구분됩니다. 현재, 의료기기 프로바이더 부문이 제조 실행 시스템 시장에서 가장 높은 비율(-51%)을 차지하고 있습니다. 게다가 생명과학 및 바이오 테크놀로지 기업 부문은 배치 생산 관리, 추적, 재료나 제품의 트레이스를 지원하는 MES에 대한 의존도가 높기 때문에 상대적으로 높은 CAGR로 성장할 가능성이 높습니다.
주요 지역별로 보면, 시장은 북미, 유럽, 아시아태평양, 중동 및 아프리카, 기타 지역으로 구분됩니다. 현재 유럽(-41%)이 제조 실행 시스템 시장을 독점하고, 최대의 수익 점유율을 차지하고 있습니다. 그러나 아시아태평양 지역의 시장은 예측 기간 동안 16.8%라는 높은 CAGR로 성장할 것으로 예상되고 있습니다.
제조 실행 시스템 시장의 진출기업 예
Andea
Critical Manufacturing
Dassault Systemes
GE Digital
Infor
Korber
Rockwell Automation
이 보고서는 전 세계의 제조 실행 시스템 시장에 대해 조사했으며, 시장 개요와 함께 전개 유형별, 최종 사용자별 동향, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.
목차
제1장 서문
제2장 주요 요약
제3장 서문
제조 실행 시스템 개요
제조 실행 시스템 핵심 기능
제조 실행 시스템 도입 모델
제조 실행 시스템이 제공하는 이점
제조 실행 시스템과 관련된 과제
다른 운영을 위한 제조 실행 시스템 통합
결론
제4장 시장 상황
제4장 헬스케어의 제조 실행 시스템 프로바이더 : 시장 개요
헬스케어의 제조 실행 시스템 프로바이더 일람
설립 연별 분석
기업 규모별 분석
본사 소재지별 분석
전개 유형별 분석
소프트웨어 통합별 분석
라이선스 유형별 분석
최종 사용자 유형별 분석
주요 특징별 분석
제공되는 서비스 유형별 분석
취득한 품질인증별 분석
제5장 중요한 인사이트
제6장 파트너십 및 협업
제7장 기업 경쟁력 분석
헬스케어의 제조 실행 시스템 프로바이더 : 기업 경쟁력 분석
전제 및 주요 파라미터
조사 방법
포트폴리오의 힘의 벤치마크
파트너십 활동의 벤치마킹
기업 경쟁력 분석 : 초대형 기업
기업 경쟁력 분석 : 대기업
기업 경쟁력 분석 : 중규모 기업
기업 경쟁력 분석 : 소규모 기업
제8장 기업 프로파일
Andea
Critical Manufacturing
Dassault Systemes
GE Digital
Infor
Korber
Rockwell Automation
제9장 가치 창조 프레임워크 : 제조 실행 시스템의 미충족 요구에 대응하기 위한 전략 가이드
헬스케어 업계에서 제조 실행 시스템에 대한 미충족 요구
주요 전제 및 조사 방법
주요 도구 및 기술
혁신의 정도 및 그에 따른 위험
결론
제10장 시장 예측
주요 전제 및 예측 조사 방법
예측되는 시장 부문
헬스케어 시장의 제조 실행 시스템 프로바이더(-2035년)
헬스케어 시장의 제조 실행 시스템 프로바이더(-2035년) : 전개 유형별 분석
헬스케어 시장의 제조 실행 시스템 프로바이더(-2035년) : 최종 사용자별 분석
헬스케어 시장의 제조 실행 시스템 프로바이더(-2035년) : 지역 분석
제11장 주요 인사이트
제12장 부록 I : 기타 그림
제13장 부록 II : 표 형식 데이터
제14장 부록 III : 기업 일람
AJY
영문 목차
영문목차
GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET: OVERVIEW
As per Roots Analysis, the global manufacturing execution system market is estimated to grow from USD 3.99 billion in the current year to USD 20.46 billion by 2035, at a CAGR of 16.02% during the forecast period, till 2035.
The market sizing and opportunity analysis has been segmented across the following parameters:
Type of Deployment
Cloud
Corporate Data Center
Hybrid
On Premise
Type of End-User
Life Science / Biotechnology Companies
Medical Device Providers
Pharmaceutical Companies and Others
Key Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North Africa
GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET: GROWTH AND TRENDS
Over the years, the healthcare industry has undergone substantial growth, making it essential for manufacturers to adopt new technologies and tools in order to remain relevant and competitive in the evolving market landscape. Manufacturing execution systems play a crucial role in achieving long term competitive advantages in the healthcare industry. Manufacturing execution system is a dynamic information system that connects, monitors, and synchronizes various processes of complex manufacturing processes. MES system enables enhanced plant productivity and efficiency along with increased flexibility and agility across the manufacturing processes. It also simplifies the process of complying with regulatory guidelines and facilitates healthcare companies in maintaining high quality standards during the production process.
In recent years, several healthcare stakeholders have actively undertaken initiatives to incorporate manufacturing execution systems into their production lines. In addition, players engaged in this domain are integrating advanced technologies, including internet of thing (IOT) and artificial intelligence (AI) to collect and analyze large volume of data from various sources and to produce value in the form of insights, predictions, and actions. With the healthcare industry turning towards manufacturing execution systems to make data-driven decisions about their production lines, the future of industrial processes promises greater efficiency and better opportunities for growth.
GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET: KEY INSIGHTS
The report delves into the current state of the global manufacturing execution system market and identifies potential growth opportunities within industry. Some key findings from the report include:
At present, more than 75 companies across the globe claim to offer manufacturing execution systems (MES) in order to monitor, track and control the production process in the healthcare sector.
Stakeholders are offering MES, integrated with numerous types of software, through different licensing models to serve the pharmaceutical, life science / biotechnology and medical device industries.
Over 85% of the MES providers offer such services via subscription models; the medical device industry has emerged as a prominent end user for such services.
ERP and PLM have emerged as the most prominent integration software; nearly 50% of stakeholders offer MES integrated with more than one type of software.
Nearly 15% stakeholders claim to offer MES for all end users; prominent examples include Atachi Systems, Dassault Systemes, Epicor, GE Digital, Infor and Tulip.
In order to cater to the evolving needs of clients across the world, stakeholders have established a presence across different regions; Europe has emerged as the key hub, featuring the highest number of MES providers.
The growing interest of stakeholders is also evident from the rise in partnership activity; in fact, the maximum number of collaborations were inked in the last two years.
In pursuit of building a competitive edge, manufacturing execution system providers are actively upgrading their existing capabilities to further enhance their respective service / product offerings.
Our proprietary value creation framework highlights the key tools and technologies that emerging players in this domain must integrate in order to augment their MES portfolio.
The market is expected to witness a healthy growth of over 16% in the coming decade; the opportunity is likely to be well distributed across various type of deployments, end users and different regions.
GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET: KEY SEGMENTS
Cloud Segment Occupies the Largest Share of the Manufacturing Execution System Market
Based on the type of deployment, the market is segmented into cloud, corporate datacenter, hybrid and on-premises. At present, the cloud segment holds the maximum (~69%) share of the global manufacturing execution system market due to the growing demand for cloud-based MES solutions. However, the hybrid segment is expected to grow at a higher CAGR during the forecast period.
By Type of End-User, Life Science / Biotechnology Companies is the Fastest Growing Segment of the Global Manufacturing Execution System Market
Based on the type of end-user, the market is segmented into life science / biotechnology companies, medical device providers, pharmaceutical companies and others. Currently, the medical device providers segment captures the highest proportion (~51%) of the manufacturing execution system market. Further, the life science / biotechnology companies' segment is likely to grow at a relatively higher CAGR as the companies highly rely on MES that aid in managing batch production, tracking, and tracing materials and products.
Europe Accounts for the Largest Share of the Market
Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America, and the rest of the world. Currently, Europe (~41%) dominates the manufacturing execution system market and accounts for the largest revenue share. However, the market in Asia-Pacific is expected to grow at a higher CAGR of 16.8% during the forecast period.
Example Players in the Manufacturing Execution System Market
Andea
Critical Manufacturing
Dassault Systemes
GE Digital
Infor
Korber
Rockwell Automation
PRIMARY RESEARCH OVERVIEW
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews conducted with the following industry stakeholders:
Chief Executive Officer, Company A
Chief Marketing Officer, Company B
Director of Sales, Company C
GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET
Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global manufacturing execution system market, focusing on key market segments, including [A] type of deployment, [B] type of end-user and [C] key geographical regions.
Market Landscape: A comprehensive evaluation of manufacturing execution system companies in the healthcare industry, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of deployment, [E] integrating MES software, [F] type of license, [G] type of end-user, [H] key features, [I] type of service(s) offered and [J] quality certifications received.
Key Insights: An in-depth analysis of manufacturing execution system market trends using five schematic representations, including [A] a detailed analysis, based on year of establishment and region of headquarters, [B] an analysis, based on company size and type of deployment, [C] a comprehensive analysis, based on type of license and end-user, [D] an analysis, based on company size and key features, and [E] a 4D bubble chart comparing the players engaged in MES market.
Partnerships and Collaborations: An in-depth analysis of the deals inked by stakeholders in this domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] key players (in terms of the number of partnerships signed) and [E] geographical distribution of partnership activity.
Company Competitiveness Analysis: An insightful competitive analysis of manufacturing execution system providers in the healthcare industry, examining factors, such as [A] product portfolio strength, [B] competitive index and [C] partnership strength.
Company Profiles: In-depth profiles of companies engaged in the manufacturing execution system industry, focusing on [A] company overview and [B] recent developments and an informed future outlook.
Value Creation Framework: An insightful framework depicting the implementation of several advanced tools and technologies, such as [A] artificial intelligence, [B] cloud computing, [C] internet of things and [D] machine learning.
KEY QUESTIONS ANSWERED IN THIS REPORT
How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?
REASONS TO BUY THIS REPORT
The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
ADDITIONAL BENEFITS
Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
15% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older
TABLE OF CONTENTS
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.2.1. Research Assumptions
1.2.2. Project Methodology
1.2.3. Forecast Methodology
1.2.4. Robust Quality Control
1.2.5. Key Considerations
1.2.5.1. Demographics
1.2.5.2. Economic Factors
1.2.5.3. Government Regulations
1.2.5.4. Supply Chain
1.2.5.5. COVID Impact / Related Factors
1.2.5.6. Market Access
1.2.5.7. Healthcare Policies
1.2.5.8. Industry Consolidation
1.3 Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Overview of Manufacturing Execution Systems
3.2. Core Function of Manufacturing Execution Systems
3.3. Deployment Models of Manufacturing Execution Systems
3.4. Benefits Offered by Manufacturing Execution Systems
3.5. Challenges Associated with Manufacturing Execution Systems
3.6. Integration of Manufacturing Execution Systems for Different Operations
3.7. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Manufacturing Execution System Providers in Healthcare: Market Overview
4.2. List of Manufacturing Execution System Providers in Healthcare
4.3. Analysis by Year of Establishment
4.4. Analysis by Company Size
4.5. Analysis by Location of Headquarters
4.6. Analysis by Type of Deployment
4.7. Analysis by Integrating Software
4.8. Analysis by Type of License
4.9. Analysis by Type of End User
4.10. Analysis by Key Features
4.11. Analysis by Type of Service(s) Offered
4.12. Analysis by Quality Certifications Received
5. KEY INSIGHTS
5.1. Analysis by Year of Establishment and Region of Headquarters
5.2. Analysis by Company Size and Type of Deployment
5.3. Analysis by Type of License and End User
5.4. Analysis by Company Size and Key Features
5.5. Analysis by Year of Establishment, Company Size, Type of Deployment and Quality Certifications Received (4D Bubble Chart)
6. PARTNERSHIPS AND COLLABORATIONS
6.1. Manufacturing Execution System Providers in Healthcare: Partnerships and Collaborations
6.2. Analysis by Year of Partnership
6.3. Analysis by Type of Partnership
6.4. Analysis by Year of Partnership and Type of Partnership
6.5. Analysis by Type of Partnership and Company Size
6.6. Key Players: Analysis by Number of Partnerships
6.7. Analysis by Type of Partner
6.8. Analysis by Country
6.9. Analysis by Region
6.10. Intercontinental and Intracontinental Deals
6.11. Analysis by Location of Headquarters of Partner
6.12. Analysis by Type of Partnership and Location of Headquarters of Partner
7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Manufacturing Execution System Providers in Healthcare: Company Competitiveness Analysis
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Benchmarking of Portfolio Strength
7.5. Benchmarking of Partnership Activity
7.6. Company Competitiveness Analysis: Very Large Players
7.7. Company Competitiveness Analysis: Large Players
7.8. Company Competitiveness Analysis: Mid-Sized Players
7.9. Company Competitiveness Analysis: Small Players
8. COMPANY PROFILES
8.1. Andea
8.1.1. Company Overview
8.1.2. Technology Portfolio
8.1.3. Recent Developments and Future Outlook
8.2. Critical Manufacturing
8.2.1. Company Overview
8.2.2. Technology Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. Dassault Systemes
8.3.1. Company Overview
8.3.2. Technology Portfolio
8.3.3. Recent Developments and Future Outlook
8.4. GE Digital
8.4.1. Company Overview
8.4.2. Technology Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Infor
8.5.1. Company Overview
8.5.2. Technology Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. Korber
8.6.1. Company Overview
8.6.2. Technology Portfolio
8.6.3. Recent Developments and Future Outlook
8.7. Rockwell Automation
8.7.1. Company Overview
8.7.2. Technology Portfolio
8.7.3. Recent Developments and Future Outlook
9. VALUE CREATION FRAMEWORK: A STRATEGIC GUIDE TO ADDRESS UNMET NEED FOR MANUFACTURING EXECUTION SYSTEMS
9.1. Unmet Need for Manufacturing Execution Systems in the Healthcare Industry
9.2. Key Assumptions and Methodology
9.3. Key Tools and Technologies
9.3.1. Technology 1
9.3.2. Technology 2
9.3.3. Technology 3
9.3.4. Technology 4
9.4. Extent of Innovation versus Associated Risks
9.5. Concluding Remarks
10. MARKET FORECAST
10.1. Key Assumptions and Forecast Methodology
10.2. Forecasted Market Segments
10.3. Manufacturing Execution System Providers in Healthcare Market, Till 2035
10.4. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of Deployment, Till 2035
10.4.1. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions
10.4.2. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions
10.4.3. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions
10.4.4. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions
10.5. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of End User, Till 2035
10.5.1. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies
10.5.2. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers
10.5.3. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies
10.5.4. Manufacturing Execution System Providers in Healthcare Market for Other End Users
10.6. Manufacturing Execution System Providers in Healthcare Market: Analysis by Geography, Till 2035
10.6.1. Manufacturing Execution System Providers in Healthcare Market in North America, Till 2035
10.6.2. Manufacturing Execution System Providers in Healthcare Market in Europe, Till 2035
10.6.3. Manufacturing Execution System Providers in Healthcare Market in Asia, Till 2035
10.6.4. Manufacturing Execution System Providers in Healthcare Market in Latin America, Till 2035
10.6.5. Manufacturing Execution System Providers in Healthcare Market in MENA, Till 2035
10.6.6. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, Till 2035
